Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY)

OTCMKTS · Delayed Price · Currency is USD
7.60
+0.53 (7.50%)
At close: Mar 4, 2026
Market Cap8.08B -7.6%
Revenue (ttm)39.43B +3.0%
Net Income792.98M +40.2%
EPS0.21 +41.6%
Shares Outn/a
PE Ratio10.19
Forward PE11.11
Dividend0.20 (2.64%)
Ex-Dividend DateDec 31, 2025
Volume439
Average Volume590
Open7.60
Previous Close7.07
Day's Range7.60 - 7.60
52-Week Range6.39 - 8.32
Beta0.33
RSI48.74
Earnings DateMar 30, 2026

About SHPMY

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in... [Read more]

Sector Healthcare
Founded 1994
Employees 49,402
Stock Exchange OTCMKTS
Ticker Symbol SHPMY

Financial Performance

In 2024, SHPMY's revenue was 275.25 billion, an increase of 5.75% compared to the previous year's 260.30 billion. Earnings were 4.55 billion, an increase of 20.82%.

Financial numbers in CNY Financial Statements